Increased medical expenditure from government and regulatory bodies has highly contributed to the growth in the blood testing market. The bodies have been encouraging patients to undergo regular diagnostic tests, thereby increasing the demand for services in the blood testing sector in the forecasted period. Moreover, the research activities undertaken in developed countries have also emerged as a significant contributor to this growth. For example, scientists at the National Center for Global Health and Medicine in Japan found a blood test that can offer even early signs of severe cases of COVID-19. The viability of such tests was proven by the issuance of 500 prototype machines. Ventures such as these are becoming pivotal to pushing the regional market in Asia forward.